The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Coffa, Sergio ^a   Breitman, Maya ^a   Hanson, Susan M ^a,c   Callaway, Kari ^b   Kook, Seunghyi ^a   Dalby, Kevin N ^b   Gurevich, Vsevolod V ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c CARROLL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARRESTIN 1; ARRESTIN 2; ARRESTIN 3; BETA 2 ADRENERGIC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; RAF PROTEIN; RETINA S ANTIGEN; UNCLASSIFIED DRUG; ARRESTIN3; BETA ARRESTIN; LIGAND; MAP2K1 PROTEIN, MOUSE; MUTANT PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; COW; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FIBROBLAST; HAPLORHINI; IN VITRO STUDY; MOUSE; MUTANT; NONHUMAN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN PURIFICATION; RECEPTOR BINDING; ANIMAL; ANIMAL EMBRYO; CATTLE; CELL STRAIN COS1; CELL STRAIN HEK293; CERCOPITHECUS; CHEMISTRY; CYTOLOGY; ENZYMOLOGY; HUMAN; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ARRESTIN; ARRESTINS; CATTLE; CERCOPITHECUS AETHIOPS; COS CELLS; EMBRYO, MAMMALIAN; ENZYME ACTIVATION; FIBROBLASTS; HEK293 CELLS; HUMANS; LIGANDS; MAP KINASE KINASE 1; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUTANT PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTORS, ADRENERGIC, BETA-2; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 83155164567     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028723     Document Type: Article

References (63)

1. Wilden U, Hall SW, Kühn H, (1986) Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments. Proc Natl Acad Sci USA 83: 1174-1178.
2. Krupnick JG, Gurevich VV, Benovic JL, (1997) Mechanism of quenching of phototransduction. Binding competition between arrestin and transducin for phosphorhodopsin. J Biol Chem 272: 18125-18131.
3. Wilden U, (1995) Duration and amplitude of the light-induced cGMP hydrolysis in vertebrate photoreceptors are regulated by multiple phosphorylation of rhodopsin and by arrestin binding. Biochemistry 34: 1446-1454.
4. Gurevich EV, Gurevich VV, (2006) Arrestins are ubiquitous regulators of cellular signaling pathways. Genome Biology 7: 236.
5. Han M, Gurevich VV, Vishnivetskiy SA, Sigler PB, Schubert C, (2001) Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation. Structure 9: 869-880.
6. Hirsch JA, Schubert C, Gurevich VV, Sigler PB, (1999) The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation. Cell 97: 257-269.
7. Sutton RB, Vishnivetskiy SA, Robert J, Hanson SM, Raman D, et al. (2005) Crystal Structure of Cone Arrestin at 2.3 Å: Evolution of Receptor Specificity. J Mol Biol 354: 1069-1080.
8. Zhan X, Gimenez LE, Gurevich VV, Spiller BW, (2011) Crystal structure of arrestin-3 reveals the basis of the difference in receptor binding between two non-visual arrestins. J Mol Biol 406: 467-478.
9. Ohguro H, Palczewski K, Walsh KA, Johnson RS, (1994) Topographic study of arrestin using differential chemical modifications and hydrogen/deuterium exchange. Protein Sci 3: 2428-2434.
10. Hanson SM, Francis DJ, Vishnivetskiy SA, Kolobova EA, Hubbell WL, et al. (2006) Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin. Proc Natl Acad Sci U S A 103: 4900-4905.
11. Hanson SM, Gurevich VV, (2006) The differential engagement of arrestin surface charges by the various functional forms of the receptor. J Biol Chem 281: 3458-3462.
12. Vishnivetskiy SA, Hosey MM, Benovic JL, Gurevich VV, (2004) Mapping the arrestin-receptor interface: structural elements responsible for receptor specificity of arrestin proteins. J Biol Chem 279: 1262-1268.
13. Vishnivetskiy SA, Francis DJ, Van Eps N, Kim M, Hanson SM, et al. (2010) The role of arrestin alpha-helix I in receptor binding. J Mol Biol 395: 42-54.
14. Vishnivetskiy SA, Gimenez LE, Francis DJ, Hanson SM, Hubbell WL, et al. (2011) Few residues within an extensive binding interface drive receptor interaction and determine the specificity of arrestin proteins. J Biol Chem 286: 24288-24299.
15. Pulvermuller A, Schroder K, Fischer T, Hofmann KP, (2000) Interactions of metarhodopsin II. Arrestin peptides compete with arrestin and transducin. J Biol Chem 275: 37679-37685.
16. Dinculescu A, McDowell JH, Amici SA, Dugger DR, Richards N, et al. (2002) Insertional mutagenesis and immunochemical analysis of visual arrestin interaction with rhodopsin. J Biol Chem 277: 11703-11708.
17. Schleicher A, Kuhn H, Hofmann KP, (1989) Kinetics, binding constant, and activation energy of the 48-kDa protein-rhodopsin complex by extra-metarhodopsin II. Biochemistry 28: 1770-1775.
18. Palczewski K, Pulvermuller A, Buczylko J, Hofmann KP, (1991) Phosphorylated rhodopsin and heparin induce similar conformational changes in arrestin. J Biol Chem 266: 18649-18654.
19. Gurevich VV, Gurevich EV, (2004) The molecular acrobatics of arrestin activation. Trends Pharmacol Sci 25: 105-111.
20. Gurevich VV, Gurevich EV, (2006) The structural basis of arrestin-mediated regulation of G protein-coupled receptors. Pharm Ther 110: 465-502.
21. Gurevich VV, Hanson SM, Song X, Vishnivetskiy SA, Gurevich EV, (2011) The functional cycle of visual arrestins in photoreceptor cells. Prog Retin Eye Res 30: 405-430.
22. Hanson SM, Cleghorn WM, Francis DJ, Vishnivetskiy SA, Raman D, et al. (2007) Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity. J Mol Biol 368: 375-387.
23. Hanson SM, Francis DJ, Vishnivetskiy SA, Klug CS, Gurevich VV, (2006) Visual arrestin binding to microtubules involves a distinct conformational change. J Biol Chem 281: 9765-9772.
24. Gurevich VV, Gurevich EV, Cleghorn WM, (2008) Arrestins as multi-functional signaling adaptors. Handb Exp Pharmacol 186: 15-37.
25. Song X, Raman D, Gurevich EV, Vishnivetskiy SA, Gurevich VV, (2006) Visual and both non-visual arrestins in their "inactive" conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm. J Biol Chem 281: 21491-21499.
26. Song X, Gurevich EV, Gurevich VV, (2007) Cone arrestin binding to JNK3 and Mdm2: conformational preference and localization of interaction sites. J Neurochem 103: 1053-1062.
27. Ahmed MR, Zhan X, Song X, Kook S, Gurevich VV, et al. (2011) Ubiquitin ligase parkin promotes Mdm2-arrestin interaction but inhibits arrestin ubiquitination. Biochemistry 50: 3749-3763.
28. Vishnivetskiy SA, Hirsch JA, Velez MG, Gurevich YV, Gurevich VV, (2002) Transition of arrestin into the active receptor-binding state requires an extended interdomain hinge. J Biol Chem 277: 43961-43967.
29. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, et al. (2001) Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci U S A 98: 2449-2454.
30. Coffa S, Breitman M, Spiller BW, Gurevich VV, (2011) A single mutation in arrestin-2 prevent ERK1/2 activation by reducing c-Raf1 binding. Biochemistry 50: 6951-6958.
31. Song X, Coffa S, Fu H, Gurevich VV, (2009) How does arrestin assemble MAPKs into a signaling complex? J Biol Chem 284: 685-695.
32. Celver J, Vishnivetskiy SA, Chavkin C, Gurevich VV, (2002) Conservation of the phosphate-sensitive elements in the arrestin family of proteins. J Biol Chem 277: 9043-9048.
33. Gurevich VV, Pals-Rylaarsdam R, Benovic JL, Hosey MM, Onorato JJ, (1997) Agonist-receptor-arrestin, an alternative ternary complex with high agonist affinity. J Biol Chem 272: 28849-28852.
34. Gurevich VV, Dion SB, Onorato JJ, Ptasienski J, Kim CM, et al. (1995) Arrestin interaction with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, b2-adrenergic, and m2 muscarinic cholinergic receptors. J Biol Chem 270: 720-731.
35. Kovoor A, Celver J, Abdryashitov RI, Chavkin C, Gurevich VV, (1999) Targeted construction of phosphorylation-independent b-arrestin mutants with constitutive activity in cells. J Biol Chem 274: 6831-6834.
36. Pan L, Gurevich EV, Gurevich VV, (2003) The nature of the arrestin x receptor complex determines the ultimate fate of the internalized receptor. J Biol Chem 278: 11623-11632.
37. Carter JM, Gurevich VV, Prossnitz ER, Engen JR, (2005) Conformational differences between arrestin2 and pre-activated mutants as revealed by hydrogen exchange mass spectrometry. J Mol Biol 351: 865-878.
38. Song X, Vishnivetskiy SA, Gross OP, Emelianoff K, Mendez A, et al. (2009) Enhanced Arrestin Facilitates Recovery and Protects Rod Photoreceptors Deficient in Rhodopsin Phosphorylation. Curr Biol 19: 700-705.
39. Meng D, Lynch MJ, Huston E, Beyermann M, Eichhorst J, et al. (2009) MEK1 binds directly to betaarrestin1, influencing both its phosphorylation by ERK and the timing of its isoprenaline-stimulated internalization. J Biol Chem 284: 11425-11435.
40. Samama P, Cotecchia S, Costa T, Lefkowitz RJ, (1993) A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 268: 4625-4636.
41. Gurevich VV, (1998) The selectivity of visual arrestin for light-activated phosphorhodopsin is controlled by multiple nonredundant mechanisms. J Biol Chem 273: 15501-15506.
42. Bokoch MP, Zou Y, Rasmussen SG, Liu CW, Nygaard R, et al. (2010) Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature 463: 108-112.
43. Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, et al. (2003) Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci U S A 100: 11406-11411.
44. Luo J, Busillo JM, Benovic JL, (2008) M3 muscarinic acetylcholine receptor-mediated signaling is regulated by distinct mechanisms. Mol Pharmacol 74: 338-347.
45. Kohout TA, Lin FS, Perry SJ, Conner DA, Lefkowitz RJ, (2001) beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc Nat Acad Sci USA 98: 1601-1606.
46. Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, et al. (2003) Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci U S A 100: 11406-11411.
47. McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, et al. (2000) Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290: 1515-1518.
48. Bruchas MR, Macey TA, Lowe JD, Chavkin C, (2006) Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes. J Biol Chem 281: 18081-18089.
49. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, et al. (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65: 663-675.
50. Pierce KL, Luttrell LM, Lefkowitz RJ, (2001) New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20: 1532-1539.
51. Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, Luttrell LM, (2002) beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J Biol Chem 277: 9429-9436.
52. Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, Luttrell LM, (2002) beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J Biol Chem 277: 9429-9436.
53. Good M, Tang G, Singleton J, Reményi A, Lim WA, (2009) The Ste5 scaffold directs mating signaling by catalytically unlocking the Fus3 MAP kinase for activation. Cell 136: 1085-1097.
54. Zhan X, Kaoud TS, Dalby KN, Gurevich VV, (2011) Non-visual arrestins function as simple scaffolds assembling MKK4- JNK3α2 signaling complex. Biochemistry 50 in press.
55. Song X, Coffa S, Fu H, Gurevich VV, (2009) How does arrestin assemble MAPKs into a signaling complex? J Biol Chem 284: 685-695.
56. Ahn S, Wei H, Garrison TR, Lefkowitz RJ, (2004) Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2. J Biol Chem 279: 7807-7811.
57. Rasmussen SG, Devree BT, Zou Y, Kruse AC, Chung KY, et al. (2011) Crystal structure of the β (2) adrenergic receptor-Gs protein complex. Nature 477: 549-555.
58. Gurevich VV, Benovic JL, (2000) Arrestin: mutagenesis, expression, purification, and functional characterization. Methods Enzymol 315: 422-437.
59. Vishnivetskiy SA, Raman D, Wei J, Kennedy MJ, Hurley JB, et al. (2007) Regulation of arrestin binding by rhodopsin phosphorylation level. J Biol Chem 282: 32075-32083.
60. Waas WF, Rainey MA, Szafranska AE, Dalby KN, (2003) Two rate-limiting steps in the kinetic mechanism of the serine/threonine specific protein kinase ERK2: a case of fast phosphorylation followed by fast product release. Biochemistry 42: 12273-12286.
61. Hanson SM, Van Eps N, Francis DJ, Altenbach C, Vishnivetskiy SA, et al. (2007) Structure and function of the visual arrestin oligomer. EMBO J 26: 1726-1736.
62. Song X, Vishnivetskiy SA, Seo J, Chen J, Gurevich EV, et al. (2011) Arrestin-1 expression in rods: balancing functional performance and photoreceptor health. Neuroscience 174: 37-49.
63. Hanson SM, Gurevich EV, Vishnivetskiy SA, Ahmed MR, Song X, et al. (2007) Each rhodopsin molecule binds its own arrestin. Proc Nat Acad Sci USA 104: 3125-3128.